Neulasta

Latest stories

8d
FOX Business
Amgen Inc. vs. Biogento recommend the FDA license GP2015 as abiosimilarto Amgen's top product. Amge
Amgen Inc. vs. Biogen
FOX Business / Posted 8 days ago
to recommend the FDA license GP2015 as abiosimilarto Amgen's top product. Amgen's second most important product is Neulasta, which boosts chemotherapy patients' white blood cell counts. Neulasta caught a break recently -- Novartisdisclosed... Read more
8d
FOX Business
Amgen Inc. vs. Biogento recommend the FDA license GP2015 as abiosimilarto Amgen's top product. Amge
Amgen Inc. vs. Biogen
FOX Business / Posted 8 days ago
to recommend the FDA license GP2015 as abiosimilarto Amgen's top product. Amgen's second most important product is Neulasta, which boosts chemotherapy patients' white blood cell counts. Neulasta caught a break recently -- Novartisdisclosed... Read more
21d
FOX Business
Insulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9%Revenue soared 92% to $14.4million. As with last quarter, this increase was lar
Insulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9%
FOX Business / Posted 21 days ago
Revenue soared 92% to $14.4million. As with last quarter, this increase was largely driven by the success ofAmgen'sNeulasta Onpro kit, which includes Insulet's OmniPod technology. CEO Patrick Sullivan stated that Amgen said on its earnings... Read more
3 related stories
21d
FOX Business
Insulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9%Revenue soared 92% to $14.4million. As with last quarter, this increase was lar
Insulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9%
FOX Business / Posted 21 days ago
Revenue soared 92% to $14.4million. As with last quarter, this increase was largely driven by the success ofAmgen'sNeulasta Onpro kit, which includes Insulet's OmniPod technology. CEO Patrick Sullivan stated that Amgen said on its earnings... Read more
3 related stories
28d
Market Watch
Amgen is the latest to raise drug prices despite public outcrycancer treatment Xgeva. Price increases also helped partially offset a year ov
Amgen is the latest to raise drug prices despite public outcry
Market Watch / Posted 28 days ago
cancer treatment Xgeva. Price increases also helped partially offset a year over year sales decline for biologic drug Neulasta, which prevents infection after chemotherapy, the presentation said. Amgen noted that growth in “net selling price”... Read more
29d
Pacific Coast Business Times
Amgen reports revenue increase in second quarter earningspipeline opportunities rapidly nearing regulatory milestones.” Higher prices f
Amgen reports revenue increase in second quarter earnings
Pacific Coast Business Times / Posted 29 days ago
pipeline opportunities rapidly nearing regulatory milestones.” Higher prices for top-selling products Enbrel and Neulasta led to a 3.8 percent increase in operating margin for the company, partially hampered by competition from... Read more

People in this news